
J. Casimer Jacyna
Examiner (ID: 1992, Phone: (469)295-9095 , Office: P/3754 )
| Most Active Art Unit | 3754 |
| Art Unit(s) | 3754, 2403, 3751, 2899, 3105 |
| Total Applications | 3753 |
| Issued Applications | 2853 |
| Pending Applications | 166 |
| Abandoned Applications | 747 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18364235
[patent_doc_number] => 20230145826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => FLUORESCENT LABELING AGENT AND FLUORESCENT DYE
[patent_app_type] => utility
[patent_app_number] => 17/915474
[patent_app_country] => US
[patent_app_date] => 2021-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18115
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915474
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915474 | FLUORESCENT LABELING AGENT AND FLUORESCENT DYE | Apr 1, 2021 | Pending |
Array
(
[id] => 18013276
[patent_doc_number] => 11505558
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-11-22
[patent_title] => Antiviral heterocyclic compounds
[patent_app_type] => utility
[patent_app_number] => 17/220300
[patent_app_country] => US
[patent_app_date] => 2021-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50537
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 413
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17220300
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/220300 | Antiviral heterocyclic compounds | Mar 31, 2021 | Issued |
Array
(
[id] => 18361879
[patent_doc_number] => 20230143470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ
[patent_app_type] => utility
[patent_app_number] => 17/915559
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10357
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915559
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915559 | SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ | Mar 29, 2021 | Pending |
Array
(
[id] => 16977572
[patent_doc_number] => 20210221809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => AZAINDOLE DERIVATIVES AND THEIR USE AS ERK KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/216114
[patent_app_country] => US
[patent_app_date] => 2021-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 256
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17216114
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/216114 | Azaindole derivatives and their use as ERK kinase inhibitors | Mar 28, 2021 | Issued |
Array
(
[id] => 18004913
[patent_doc_number] => 20220363679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => ARYL PIPERIDINES AS MONOACYLGLYCEROL LIPASE MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/212274
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17212274
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/212274 | Aryl piperidines as monoacylglycerol lipase modulators | Mar 24, 2021 | Issued |
Array
(
[id] => 18020531
[patent_doc_number] => 20220372030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => MONOACYLGLYCEROL LIPASE MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/212377
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34376
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17212377
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/212377 | Monoacylglycerol lipase modulators | Mar 24, 2021 | Issued |
Array
(
[id] => 17243396
[patent_doc_number] => 20210363139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => CXCR4 INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/208774
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65472
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17208774
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/208774 | CXCR4 INHIBITORS AND USES THEREOF | Mar 21, 2021 | Abandoned |
Array
(
[id] => 19608855
[patent_doc_number] => 12157721
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Process for the preparation of methyl 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylate
[patent_app_type] => utility
[patent_app_number] => 17/193706
[patent_app_country] => US
[patent_app_date] => 2021-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4907
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17193706
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/193706 | Process for the preparation of methyl 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylate | Mar 4, 2021 | Issued |
Array
(
[id] => 18266146
[patent_doc_number] => 20230087388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => INHIBITORS OF HUMAN DEUBIQUITINASES FOR THE TREATMENT OF CORONAVIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/802886
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17802886
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/802886 | INHIBITORS OF HUMAN DEUBIQUITINASES FOR THE TREATMENT OF CORONAVIRAL INFECTIONS | Feb 25, 2021 | Pending |
Array
(
[id] => 18285064
[patent_doc_number] => 20230100536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => INTERCELLULAR AND INTRACELLULAR PROXIMITY-BASED LABELING COMPOSITIONS AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/802823
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11530
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17802823
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/802823 | INTERCELLULAR AND INTRACELLULAR PROXIMITY-BASED LABELING COMPOSITIONS AND SYSTEMS | Feb 25, 2021 | Pending |
Array
(
[id] => 18347280
[patent_doc_number] => 20230135390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => PROCESS FOR MANUFACTURE OF A COMPLEXING AGENT
[patent_app_type] => utility
[patent_app_number] => 17/908819
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2996
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908819
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/908819 | PROCESS FOR MANUFACTURE OF A COMPLEXING AGENT | Feb 24, 2021 | Pending |
Array
(
[id] => 18071370
[patent_doc_number] => 11530192
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-20
[patent_title] => Crystalline and salt forms of PPAR agonist compounds
[patent_app_type] => utility
[patent_app_number] => 17/179604
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8851
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179604
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/179604 | Crystalline and salt forms of PPAR agonist compounds | Feb 18, 2021 | Issued |
Array
(
[id] => 17067198
[patent_doc_number] => 20210269413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => QUINAZOLINONE COMPOUNDS AND RELATED COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/180644
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16413
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180644
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/180644 | Quinazolinone compounds and related compounds | Feb 18, 2021 | Issued |
Array
(
[id] => 17096879
[patent_doc_number] => 20210284670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => ANTIVIRAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/178463
[patent_app_country] => US
[patent_app_date] => 2021-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 118253
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178463
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/178463 | Antiviral compounds | Feb 17, 2021 | Issued |
Array
(
[id] => 20701348
[patent_doc_number] => 12624048
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-12
[patent_title] => Photochromic cyclic compound and curable composition containing the photochromic cyclic compound
[patent_app_type] => utility
[patent_app_number] => 17/798597
[patent_app_country] => US
[patent_app_date] => 2021-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12446
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 608
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17798597
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/798597 | Photochromic cyclic compound and curable composition containing the photochromic cyclic compound | Feb 17, 2021 | Issued |
Array
(
[id] => 18347042
[patent_doc_number] => 20230135152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => PIKFYVE KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/760384
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760384
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/760384 | PIKFYVE KINASE INHIBITORS | Feb 10, 2021 | Pending |
Array
(
[id] => 18364589
[patent_doc_number] => 20230146180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => PESTICIDALLY ACTIVE CYCLIC AMINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/799232
[patent_app_country] => US
[patent_app_date] => 2021-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33042
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 505
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799232
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/799232 | Pesticidally active cyclic amine compounds | Feb 9, 2021 | Issued |
Array
(
[id] => 19738273
[patent_doc_number] => 12215091
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-04
[patent_title] => Method for producing methylene disulfonate compound
[patent_app_type] => utility
[patent_app_number] => 17/798637
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7873
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 256
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17798637
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/798637 | Method for producing methylene disulfonate compound | Feb 7, 2021 | Issued |
Array
(
[id] => 18187484
[patent_doc_number] => 11578052
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/162157
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 23027
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17162157
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/162157 | PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof | Jan 28, 2021 | Issued |
Array
(
[id] => 20271957
[patent_doc_number] => 12441726
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/795778
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 105903
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795778
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795778 | Compounds and uses thereof | Jan 28, 2021 | Issued |